Table 2 Management in the intensive care unit and characteristics on discharge
No or mild symptoms at 3 months N = 426 | Significant symptoms at 3 months N = 388 | P value | |
|---|---|---|---|
SAPS 2 | 33 (± 16) | 32 (± 16) | 0.8 |
Surgery during ICU stay | |||
Intra-cranial | 19 (4.5%) | 17 (4.4%) | > 0.9 |
Spinal | 4 (0.9%) | 19 (4.9%) | 0.001 |
Orthopaedics | 23 (5.4%) | 55 (14.2%) | < 0.001 |
Intra-abdominal | 132 (31%) | 107 (27.6%) | 0.3 |
Thoracic | 64 (15%) | 50 (12.3%) | 0.4 |
Pleural drainage | 32 (7.5%) | 34 (8.7%) | 0.6 |
Number of interventions during ICU | 1 [0–1] | 1 [0–1] | 0.6 |
Pain management | |||
Continuous Morphine | 196 (46%) | 170 (43.8%) | 0.6 |
Remifentanil | 41 (9.6%) | 51 (13.1%) | 0.1 |
Continuous Ketamine | 49 (11.5%) | 61 (15.8%) | 0.1 |
Gabapentin, Pregabalin | 42 (9.9%) | 50 (12.9%) | 0.2 |
Loco-regional anesthesia | 84 (19.7%) | 98 (25.3%) | 0.1 |
Pain symptoms on discharge | |||
Numeric Rating Scale | 2 [1–4] | 4 [2 –6] | < 0.001 |
ID pain score | 0 [0–1] | 1 [0–2] | < 0.001 |
ID pain score > 3 | 10 (2.3%) | 22 (5.6%) | 0.02 |
Pain location | |||
Head | 26 (6.1%) | 33 (8.5%) | 0.2 |
Abdominal | 105 (24.7%) | 101 (26%) | 0.8 |
Limb | 61 (14.3%) | 86 (22.1%) | 0.005 |
Joint | 27 (6.3%) | 29 (7.5%) | 0.6 |
Thorax | 59 (13.9%) | 75 (19.3%) | 0.04 |
Back | 23 (5.4%) | 60 (15.5%) | < 0.001 |
ICU complications | |||
Acute respiratory distress syndrome | 45 (10.6%) | 39 (10.1%) | 0.9 |
Prone positioning | 19 (4.5%) | 29 (7.5%) | 0.1 |
Neuro-muscular blocking agents | 54 (12.7%) | 48 (12.5%) | 0.9 |
Invasive mechanical ventilation duration (days) | 0 [0–2] | 0 [0–2] | 0.5 |
ICU length of stay (days) | 6 [4–12] | 6 [4–11] | 0.9 |